Influenza Viral Infections
20
0
2
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
1 terminated out of 20 trials
91.7%
+5.2% vs benchmark
25%
5 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (20)
Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach
Reducing Respiratory Virus Transmission in Bangladeshi Classrooms
Single Dose Texas 2017 (H3N2) Challenge Study
Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model
Infection Watch Study
An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh
Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers
Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease
Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician
Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children
Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine
Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room
Nasal Swab Home Collection Kit (NSHC Kit) Study
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy
Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa
Intradermal Influenza Vaccine in the Young